- Home
- EVH vs CPRI Comparison
EVH vs CPRI Comparison
Compare EVH & CPRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVH
- CPRI
- Stock Information
- Founded
- EVH 2011
- CPRI 1981
- Country
- EVH United States
- CPRI United Kingdom
- Employees
- EVH N/A
- CPRI N/A
- Industry
- EVH Other Consumer Services
- CPRI Apparel
- Sector
- EVH Consumer Discretionary
- CPRI Consumer Discretionary
- Exchange
- EVH Nasdaq
- CPRI Nasdaq
- Market Cap
- EVH 1.0B
- CPRI 2.2B
- IPO Year
- EVH 2015
- CPRI 2011
- Fundamental
- Price
- EVH $8.77
- CPRI $21.52
- Analyst Decision
- EVH Strong Buy
- CPRI Buy
- Analyst Count
- EVH 15
- CPRI 11
- Target Price
- EVH $17.27
- CPRI $23.64
- AVG Volume (30 Days)
- EVH 3.1M
- CPRI 2.7M
- Earning Date
- EVH 11-06-2025
- CPRI 11-06-2025
- Dividend Yield
- EVH N/A
- CPRI N/A
- EPS Growth
- EVH N/A
- CPRI N/A
- EPS
- EVH N/A
- CPRI N/A
- Revenue
- EVH $2,195,920,000.00
- CPRI $4,391,000,000.00
- Revenue This Year
- EVH N/A
- CPRI N/A
- Revenue Next Year
- EVH $28.38
- CPRI $3.75
- P/E Ratio
- EVH N/A
- CPRI N/A
- Revenue Growth
- EVH N/A
- CPRI N/A
- 52 Week Low
- EVH $7.06
- CPRI $11.86
- 52 Week High
- EVH $31.67
- CPRI $43.34
- Technical
- Relative Strength Index (RSI)
- EVH 41.75
- CPRI 54.05
- Support Level
- EVH $8.43
- CPRI $20.42
- Resistance Level
- EVH $10.08
- CPRI $21.96
- Average True Range (ATR)
- EVH 0.41
- CPRI 0.98
- MACD
- EVH -0.09
- CPRI -0.03
- Stochastic Oscillator
- EVH 21.15
- CPRI 62.72
About EVH Evolent Health Inc
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
About CPRI Capri Holdings Limited
Capri Holdings is a marketer, distributor, and retailer of upscale accessories and apparel in the Americas, Europe, and Asia. Michael Kors, Capri's original and largest brand by sales, offers handbags, footwear, and apparel through more than 700 company-owned stores, wholesale, and e-commerce. Jimmy Choo (acquired in 2017) is best known for women's luxury footwear. Its products are sold in more than 200 company-operated stores. Capri also owns a third brand, Versace, but has agreed to sell it to Prada. John Idol has served as Capri's CEO since 2003.